Aspirin at giant cell arteritis diagnosis reduces heart risk, increases hemorrhage odds

Low-dose aspirin initiated giant cell arteritis diagnosis reduced the risk for major adverse cardiac events at 1 and 3 years, but increased risk for major hemorrhage at 1 year, according to data published in JAMA Network Open.“As in other inflammatory diseases,1 patients with GCA face an elevated risk of cardiovascular disease (CVD),” Maxime Beydon, MD, MPH, of Sorbonne University and